W2ST34 Stock Overview
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
West Pharmaceutical Services, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$57.72 |
| 52 Week High | US$57.72 |
| 52 Week Low | US$48.05 |
| Beta | 1.02 |
| 1 Month Change | 16.96% |
| 3 Month Change | 16.96% |
| 1 Year Change | 13.18% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -12.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| W2ST34 | BR Life Sciences | BR Market | |
|---|---|---|---|
| 7D | 5.3% | 0% | 0% |
| 1Y | 13.2% | 0% | 0% |
Return vs Industry: W2ST34 exceeded the BR Life Sciences industry which returned -12.1% over the past year.
Return vs Market: W2ST34 matched the BR Market which returned 13.1% over the past year.
Price Volatility
| W2ST34 volatility | |
|---|---|
| W2ST34 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in BR Market | 0% |
| 10% least volatile stocks in BR Market | 0% |
Stable Share Price: W2ST34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine W2ST34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1923 | 10,600 | Eric Green | www.westpharma.com |
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.
West Pharmaceutical Services, Inc. Fundamentals Summary
| W2ST34 fundamental statistics | |
|---|---|
| Market cap | R$146.53b |
| Earnings (TTM) | R$3.04b |
| Revenue (TTM) | R$15.13b |
48.1x
P/E Ratio9.7x
P/S RatioIs W2ST34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| W2ST34 income statement (TTM) | |
|---|---|
| Revenue | US$2.95b |
| Cost of Revenue | US$1.82b |
| Gross Profit | US$1.13b |
| Other Expenses | US$536.60m |
| Earnings | US$593.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
| Earnings per share (EPS) | 8.11 |
| Gross Margin | 38.31% |
| Net Profit Margin | 20.12% |
| Debt/Equity Ratio | 7.2% |
How did W2ST34 perform over the long term?
See historical performance and comparison